A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
St. Jude Children's Research Hospital
NRG Oncology
Mayo Clinic
Yale University
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Milton S. Hershey Medical Center
Massachusetts General Hospital
AC Camargo Cancer Center
Centre Leon Berard
University of California, San Francisco
Chinese PLA General Hospital
NRG Oncology
Stanford University
University Hospital, Antwerp
Dana-Farber Cancer Institute
University of Southern California
Masonic Cancer Center, University of Minnesota
University of Florida
M.D. Anderson Cancer Center
SCRI Development Innovations, LLC
City of Hope Medical Center
Duke University
Emory University
Emory University
Cambridge University Hospitals NHS Foundation Trust
Stanford University
Yale University
Swiss Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
University of Southern California
M.D. Anderson Cancer Center
Stanford University
Institut Claudius Regaud
Yale University
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center